Reuters logo
BRIEF-Tonix to present data from Phase 2 clinical study of TNX-102 SL
May 26, 2016 / 12:47 PM / a year ago

BRIEF-Tonix to present data from Phase 2 clinical study of TNX-102 SL

May 26 (Reuters) - Tonix Pharmaceuticals Holding Corp :

* Will present positive data from Phase 2 dose-finding clinical study of TNX-102 SL for treatment of military-related PTSD Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below